Always consult your doctor before changing venlafaxine formulations (immediate-release, extended-release, or others). Sudden switches can lead to withdrawal symptoms or altered drug levels in your bloodstream. This is particularly important when moving from immediate-release to extended-release, as the extended-release version provides a more gradual release of the medication.
Transitioning to Extended-Release
Switching to extended-release venlafaxine typically requires a careful titration process. Your doctor will likely gradually reduce your immediate-release dose while simultaneously increasing your extended-release dose over several weeks to minimize withdrawal effects. This gradual change ensures a consistent level of the medication in your system.
Switching Between Extended-Release Formulations
Even between different extended-release formulations, direct substitution isn’t always recommended. While some formulations are bioequivalent, others might have slightly different release profiles. Your physician will assess your individual needs and make the appropriate recommendations. Close monitoring of your symptoms during any change is necessary.
Remember that individual responses to medication vary, making personalized advice from your healthcare professional vital.
